Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Indian Drug Makers Offer Deal To Avoid Increased Price Controls

This article was originally published in PharmAsia News

Executive Summary

Drug makers in India are offering to sell some of their more important products at half of their maximum retail price to stave off greater price controls. But their offer is conditioned on the Indian government promising not to expand its cost-based price control policy. In addition to the half-off offer on some drugs, companies are offering to contribute a quarter of a percent of total profits to the government. An acceptance by the government would be considered a big change in the way India deals with the increasing cost of health care. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts